Monopotassium Phosphate/Dipotassium Phosphate

磷酸二氢钾/磷酸氢二钾

Report date: 2023/07/26 20:00:30

Base Information

Drug NameMonopotassium Phosphate/Dipotassium Phosphate
Drug Alias NameComplex potassium hydrogen phosphate复合磷酸氢钾注射液potassium phosphate dibasic+potassium phosphate monobasicPOTASSIUM PHOSPHATES
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsParenteral Nutrition, TotalHypophosphatemia
Global Approved IndicationsHypophosphatemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes monopotassium phosphatedipotassium phosphate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCmp Development Llc
Active IndicationsParenteral Nutrition, Total
Inactive IndicationsHypophosphatemia

Other Information

ATC CodeB05BA
Related LinksN/A